Bedel Financial Consulting’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,200
Closed -$55K 282
2022
Q1
$55K Hold
1,200
0.02% 373
2021
Q4
$58K Buy
+1,200
New +$56.8K 0.02% 371

Other funds holding BME

Bedel Financial Consulting's BME Position: Q2 2022 in Review

Bedel Financial Consulting sold out of BlackRock Health Sciences Trust (BME) in Q2 2022, closing a stake of 1,200 shares — an estimated $55K sold.

Bedel Financial Consulting first reported a position in BME in Q4 2021 and held it in 2 quarters. The position peaked at $58K in Q4 2021. 62 funds tracked by Wall St. Rank hold BME as of Q2 2022.

  • Bedel Financial Consulting reported no remaining BlackRock Health Sciences Trust position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 1,200 BlackRock Health Sciences Trust shares in Q2 2022, an estimated $55K.
  • Bedel Financial Consulting first reported a position in BlackRock Health Sciences Trust in Q4 2021 and held it in 2 quarters.
  • Bedel Financial Consulting's BlackRock Health Sciences Trust position peaked at $58K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.